MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

Misys - Preliminary Results Interview With CEO

— LONDON, July 23

LONDON, July 23 /PRNewswire/ -- Misys, the banking and healthcare software group, reported continued growth despite the turmoil in financial markets.

The group's full year results have been boosted by a market beating performance at its Allscripts/Misys healthcare joint venture in the US.

In a video interview, CEO Mike Lawrie conceded there are some areas of weakness such as the Treasury and Capital Markets business.

"We did not close some of the deals that we had anticipated closing. Fortunately we are getting some of those closed now in this new year."

Mr Lawrie is, however, certain the overall business is well positioned. He said: "We can continue to execute and deliver growth, revenue growth, profit growth, margin expansion, even if the environment does not materially improve."

The full interview and transcript are available now on http://w3.cantos.com/misys. A live analyst presentation will be available at 0900BST with an on-demand replay later in the day.

It's free to view. All you need to do is register at http://www.cantos.com. Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email enquiries@cantos.com or phone +44(0)207-936-1333.

Related news

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us